Warren Ferguson to Cost-Benefit Analysis
This is a "connection" page, showing publications Warren Ferguson has written about Cost-Benefit Analysis.
Connection Strength
0.093
-
Spaulding AS, Kim AY, Harzke AJ, Sullivan JC, Linas BP, Brewer A, Dickert J, McGovern BH, Strick LB, Trestman R, Ferguson WJ. Impact of new therapeutics for hepatitis C virus infection in incarcerated populations. Top Antivir Med. 2013 Feb-Mar; 21(1):27-35.
Score: 0.093